While current antidepressants mainly target neurotransmitters such as serotonin, they only help about half of patients and often produce side effects. Seeking new biological mechanisms, researchers at the Institute for Basic Science (IBS) have discovered a novel molecular pathway linking tiny sugar molecules in the brain to depressive behavior — a breakthrough that could redefine how depression is diagnosed and treated....<<<Read More>>>...